Assessment of beneficial effects on left ventricular hypertrophy and diastolic function by metformin in hypertensive patients with type2 DM - Assessment of beneficial effects on left ventricular hypertrophy and diastolic function by metformin

ational Hospital Organization Kyoto Medical Center0 sites440 target enrollmentOctober 7, 2011

Overview

No summary available.

Registry

who.int

Start Date

October 7, 2011

End Date

September 1, 2015

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

ational Hospital Organization Kyoto Medical Center

•1\) Patients with type 1 and 2 diabetes mellitus under insulin treatment or secondary diabetes patients 2\) Patients with serious hepatic dysfunction/hepatic cirrhosis 3\) Patients with unstable angina, acute myocardial infarction, severe coronary artery disease patients (Left Main Trunk or triple\-vessel disease) 4\) Patients with chronic atrial fibrillation or pacemaker patients 5\) Patients with past lactic acidosis 6\) Patients with severe dysfunction in cardiovascular system, pulmonary function disabled shock (such as heart failure, myocardial infarction, pulmonary embolism) and with easy to develop other hypoxemia 7\) Heavy drinker 8\) Patients with gastrointestinal disorder such as diarrhea and vomiting that worried dehydration 9\) Patients with severe ketosis, diabetic coma orprecoma patients 10\) Patients with severe infection, perioperative, severe injury 11\) Those with malnutrition, starvation, debilitation, pituitary insufficiency or adrenal insufficiency patients 12\) Those with allergic response for the object medicine 13\) Pregnant and lactating patients or the patient who wishes to become pregnant 14\) Those who judged inappropriate for the clinical trial